Daily non-political popular news in brief.

Cancer stem cells similar to normal stem cells can thwart anti-cancer agents

06-15-2007 · EurekAlert!

Current cancer therapies often are thwarted because they cannot eliminate a small reservoir of multiple-drug-resistant tumor cells. Researchers at the University of Pittsburgh School of Medicine suggests that for chemotherapy to be truly effective in treating lung cancers, for example, it must be able to target a small subset of cancer stem cells, which they have shown share the same protective mechanisms as normal lung stem cells.

Keywords: cancer, stem, cells, similar, normal, thwart, anti-cancer, agents, cell, anti, agent

« Previous | Next »

Similar news on "Cancer stem cells similar to normal stem cells can thwart anti-cancer agents":

Forever young: Differentiation blocked in tumor stem cells
01-07-2008 · EurekAlert!
A new comparison of normal stem cells and cancer stem cells reveals that the cancer stem cells are abnormally trapped at an early stage of development. The research, published by Cell Press in the January issue of Cancer Cell, significantly advances the understanding of glioma pathophysiology and provides new directions for design of therapeutic strategies that are targeted to specific types of tumors.
Similar news · Read more »
Cancer cells enlist adult stem cells to promote metastasis
10-31-2007 · Massachusetts Institute of Technology (MIT)
MIT and Whitehead institute scientists have managed to facilitate metastasis, finding evidence that some breast cancer cells recruit normal adult stem cells from bone marrow and force them to secrete a protein that fosters cancer cell movement and invasion.
Similar news · Read more »
Cancer stem cell marker also drives transcription in normal cells
01-17-2008 · EurekAlert!
New research links the recently discovered function of a multi-faceted transcriptional complex to control of gene expression in both normal cells and cancer stem cells...
Similar news · Read more »
'Mini transplant' patients' outcomes similar using related and unrelated donor cells
12-03-2007 · EurekAlert!
People who undergo nonmyeloablative stem-cell transplants, or 'mini transplants,' for leukemia, lymphoma and other blood cancers have comparable outcomes regardless of whether they receive tissue-matched stem cells from a related or unrelated donor, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
Similar news · Read more »
Tumor-reactive T cells boosted by hematopoietic stem cell transplantation
02-01-2007 · EurekAlert!
Treatment for skin cancer by infusion of tumor-reactive T cells requires patients to be pre-treated with agents that transiently decrease the number of immune cells (nonmyeloablative agents). A study in mice now indicates that pre-treatment with more intense immune cell-depleting strategies (known as myeloablative strategies) and a hematopoietic stem cell transplant enables infused tumor-reactive CD8+ T cells to increase in number more than pre-treatment with nonmyeloablative agents, and this correlates with increased tumor regression.
Similar news · Read more »
New insight into factors that drive muscle-building stem cells
01-08-2008 · EurekAlert!
A report in the January issue of Cell Metabolism, a publication of Cell Press, provides new evidence explaining how stem cells known as satellite cells contribute to building muscles up in response to exercise. These findings could lead to treatments for reversing or improving the muscle loss that occurs in diseases such as cancer and AIDS as well as in the normal aging process
Similar news · Read more »
Long-term cancer risk follows stem cell transplant recipients
11-27-2006 · EurekAlert!
Hematopoietic stem cell transplant (HSCT) recipients face a significant long-term risk for developing a second cancer, particularly if they were older at the time of transplant or received stem cells from a female donor, according to a new study.
Similar news · Read more »
Cancer stem cells can go it alone
06-11-2007 · EurekAlert!
At the heart of most, if not all cancers, lie a handful of wayward stem cells that feed the ever growing tumor mass, but their scarcity make it difficult for scientists to study them. Now, times of plenty may lie ahead as a breast cancer cell line -- established long ago -- turned out to behave a lot like cancer stem cells.
Similar news · Read more »
Loss of cell's 'antenna' linked to cancer's development
06-28-2007 · EurekAlert!
Most normal vertebrate cells have cilia, small hair-like structures that protrude like antennae into the surrounding environment to detect signals that control cell growth. In a new study published in the June 29 issue of Cell, Fox Chase Cancer Center researchers describe the strong link between ciliary signaling and cancer, and identify the rogue engineers responsible for dismantling the cell's antenna.
Similar news · Read more »
Study reveals how stem cells decide to become either skeletal or smooth muscle
10-10-2007 · EurekAlert!
Researchers have discovered that a key protein controls how stem cells 'choose' to become either skeletal muscle cells that move limbs, or smooth muscle cells that support blood vessels. The results suggest new ways to treat atherosclerosis and cancer, diseases that involve the creation of new blood vessels from stem cell reserves that would otherwise replace worn out skeletal muscle.
Similar news · Read more »